ONGLYZA (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the ONGLYZA drug offered from AstraZeneca Pharmaceuticals LP. This Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | SAXAGLIPTIN |
| SUBSTANCE NAME: | SAXAGLIPTIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-11-20 |
| END MARKETING DATE: | 0000-00-00 |
ONGLYZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ONGLYZA from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2014-11-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-6100_38b7ae08-470b-4026-9830-9e8ba8006574 |
| PRODUCT NDC: | 0310-6100 |
| APPLICATION NUMBER: | NDA022350 |
Other SAXAGLIPTIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
